Submit a Revision

*your email :**
page name* : such as "Introduction", "Conclusion"..etc
<ol><li> <p> <a></a>Gallo RC: <strong>A reflection on HIV/AIDS research after 25 years. </strong> </p> <p> <em>Retrovirology</em> 2006, <strong>3</strong><strong>:</strong>72. </p> <p> </p> </li> <li> <p> <a></a>Baldwin CE, Berkhout B: <strong>HIV-1 drug-resistance and drug-dependence. </strong> </p> <p> <em>Retrovirology</em> 2007, <strong>4</strong><strong>:</strong>78. </p> <p> </p> </li> <li> <p> <a></a>Traynor K: <strong>Integrase inhibitor gains FDA approval. </strong> </p> <p> <em>Am J Health Syst Pharm</em> 2007, <strong>64</strong><strong>:</strong>2310. </p> <p> </p> </li> <li> <p> <a></a>Lo B, Padian N, Barnes M: <strong>The obligation to provide antiretroviral treatment in HIV prevention trials. </strong> </p> <p> <em>AIDS</em> 2007, <strong>21</strong><strong>:</strong>1229-1231. </p> <p> </p> </li> <li> <p> <a></a><strong>HIV vaccine failure prompts Merck to halt trial </strong> </p> <p> <em>Nature</em> 2007, <strong>449</strong><strong>:</strong>390. </p> <p> </p> </li> <li> <p> <a></a>Klasse PJ, Shattock R, Moore JP: <strong>Antiretroviral Drug-Based Microbicides to Prevent HIV-1 Sexual Transmission. </strong> </p> <p> <em>Annu Rev Med</em> 2007. </p> <p> </p> </li> <li> <p> <a></a>Shao Y: <strong>AIDS epidemic at age 25 and control efforts in China. </strong> </p> <p> <em>Retrovirology</em> 2006, <strong>3</strong><strong>:</strong>87. </p> <p> </p> </li> <li> <p> <a></a>Nielsen MH, Pedersen FS, Kjems J: <strong>Molecular strategies to inhibit HIV-1 replication. </strong> </p> <p> <em>Retrovirology</em> 2005, <strong>2</strong><strong>:</strong>10. </p> <p> </p> </li> </ol>
Confirmation code: Enter the code exactly as it appears. All letters are case insensitive, there is no zero.